This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Ulrich Blaschke, PhD
Vice President, Technical Development at BioNTech AG


Ulrich Blaschke joined BioNTech in December 2019 as VP of Technical Development. In this role, he is responsible for the implementation of an integrated CMC development strategy for the BioNTech portfolio, working closely with the technical functions and CMC regulatory affairs. Besides the technical aspects, he is specifically interested in the evolving global regulatory framework for this new class of therapeutic molecules.
Prior to BioNTech, Ulrich worked for various pharmaceutical companies in Germany and in the US, including CureVac, Boehringer Ingelheim, Cinfa Biotech, and Stada Arzneimittel.
Ulrich studied chemistry and biochemistry at the Westfälische-Wilhelms University in Münster, Germany, followed by a postdoctoral fellowship in the field of synthetic protein chemistry at the Rockefeller University, New York.

Agenda Sessions

  • mRNA Development and Manufacturing